Doris Matsui Wants a Clearinghouse for Prescription Drugs
Currently, no law enforcement agency or private party has the ability to provide real-time, nationwide oversight of all orders for controlled substances, which is a major contributing factor to disproportionate prescription opioid shipments to certain pharmacies across the country. So, Congresswoman Doris Matsui (D-CA) has introduced legislation she hopes will help address the issue. She is joined by Congressman Leonard Lance (R-NJ) in introducing the DEA Clearinghouse Act, and Senators Chris Coons (D-DE) and Cory Gardner (R-CO) have introduced companion legislation in the Senate. The lawmakers say this bill eliminates a blind spot exploited by bad actors, as well as guards against prescription drug diversion. It also would protect the integrity of the supply chain by requiring DEA to establish a national clearinghouse for all orders of controlled substances and require that all controlled substance orders pass through an automated database to identify suspicious orders and notify suppliers before the orders are filled. “We need to use every tool available to ensure prescription opioids are going to those who need them, and not to those who don’t,” said Matsui. “This legislation would consolidate data from opioid manufacturers and distributors to ensure that they and the DEA have real-time systems in place to flag and stop suspicious activity.” More here.